This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dementia due to Parkinson's disease
PD_DEMENTIA
obsolete_dementia: ['An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.']
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
887 |
4. Check minimum number of eventsNone |
887 |
5. Include endpointsNone |
887 |
6. Filter based on genotype QC (FinnGen only) |
862 |
Control definitions (FinnGen only)
- Control exclude
- G6_PARKINSON
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Dementia due to Parkinson's disease
based on the number of shared cases.
Similar with more cases:
- Dementia due to Parkinsons disease, excluding more controls
- Dementia in other diseases classified elsewhere
- Any dementia
- Any dementia, excluding more controls
- Dementia
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 862 | 308 | 554 |
| Unadjusted period prevalence (%) | 0.20 | 0.11 | 0.25 |
| Median age at first event (years) | 76.70 | 77.59 | 76.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 887
- Matched controls
- 8870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
307.7
737
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2740.9
307.7
847
68
N04BC04
ATC
ropinirole; oral
250.9
307.7
225
12
N04BC05
ATC
pramipexole; oral
19.3
307.7
402
365
N06DA03
ATC
rivastigmine; oral, transdermal
33.4
307.7
503
335
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
307.7
382
*
N04BD01
ATC
selegiline; oral
1235.4
307.7
407
6
N87
ICPC
Parkinsonism
646.6
307.7
395
11
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
307.7
814
*
G20
ICD-10 Finland
Parkinson disease
16384.0
307.7
850
6
N05AH04
ATC
quetiapine; oral
11.3
292.6
443
720
N04BD02
ATC
rasagiline; oral
+∞
243.2
222
*
193
Kela drug reimbursment
Rasagiline
+∞
197.5
182
*
N04BX02
ATC
entacapone; oral
+∞
161.5
150
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
129.4
121
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
7.3
129.2
224
392
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
37.6
126.2
79
23
N04BB01
ATC
amantadine; oral
28.1
119.5
82
32
H02AA02
ATC
fludrocortisone; oral
23.4
110.0
81
38
R25.1
ICD-10 Finland
Tremor, unspecified
12.4
106.9
111
101
N03AE01
ATC
clonazepam; systemic
7.9
101.6
154
230
N04AA02
ATC
biperiden; systemic
21.1
82.4
63
32
N04BC09
ATC
rotigotine; transdermal
132.4
69.0
73
6
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
68.6
65
*
I95.1
ICD-10 Finland
Orthostatic hypotension
5.5
68.0
148
313
R53
ICD-10 Finland
Malaise and fatigue
3.4
66.7
378
1597
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
57.9
376
1693
G04BD12
ATC
mirabegron; oral
3.6
56.5
235
807
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
55.2
471
2451
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.5
51.6
140
353
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
51.6
49
*
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
50.7
73
101
N29
ICPC
Neurological sympt/complt other
9.4
48.0
59
67
XF606
NOMESCO Finland
Ortostatic test
16.5
48.0
41
26
A06AD11
ATC
lactulose; oral
2.9
46.6
298
1303
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
10.8
45.2
50
49
N04BC06
ATC
cabergoline; oral
126.7
45.2
48
*
N19
ICPC
Speech disorder
10.5
44.6
50
50
AA1AD
NOMESCO Finland
CT of head and brain
2.7
44.4
412
2172
F0232, G20,
ICD-10 Finland
+∞
43.1
41
*
R1250
NOMESCO Finland
Evaluation of functional capability
8.8
42.8
55
66
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
16.0
42.8
37
24
F0230, G20,
ICD-10 Finland
+∞
42.0
40
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.5
41.1
83
162
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.6
40.8
68
110
SPAT1229
SPAT
Assessment of need for aid
3.4
38.5
160
539
S01.0
ICD-10 Finland
Open wound of scalp
3.5
38.4
154
507
A28
ICPC
Limited function/disability NOS
2.6
37.9
322
1599
G02CB01
ATC
bromocriptine; systemic
69.6
35.3
40
6
D21
ICPC
Swallowing problem
7.8
34.7
49
66
N04BX04
ATC
opicapone; oral
+∞
34.6
33
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.8
34.6
66
122
N04BC02
ATC
pergolide; oral
350.0
34.2
34
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.8
33.8
112
324
S72.0
ICD-10 Finland
Fracture of neck of femur
3.6
33.2
118
358
R4130
NOMESCO Finland
Speech therapy
6.3
31.9
55
92
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
114.1
30.9
33
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
30.4
401
2369
N06AB10
ATC
escitalopram; oral
2.9
30.3
169
670
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
29.4
237
1129
SPAT1216
SPAT
Assessment of functional ability
2.4
28.7
255
1267
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
28.3
27
*
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
44.1
27.9
34
8
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
149.7
27.8
29
*
SPAT1234
SPAT
Support of social functional capacity
3.3
27.5
111
364
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.9
27.5
62
133
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
27.2
332
1881
Z2445
NOMESCO Finland
Psychologist
6.5
27.2
45
72
N06AX11
ATC
mirtazapine; oral
2.2
26.3
336
1934
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.9
25.6
139
540
L28
ICPC
Limited function/disability (L)
2.3
25.5
269
1430
N05BA04
ATC
oxazepam; oral
2.2
25.2
284
1549
C07AA05
ATC
propranolol; systemic
2.6
24.7
168
732
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
24.3
218
1078
N99
ICPC
Neurological disease other
7.6
23.9
34
46
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
23.6
226
1149
U04
ICPC
Incontinence urine
3.1
23.1
102
352
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
22.8
208
1034
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.6
21.8
76
226
R41.0
ICD-10 Finland
Disorientation, unspecified
3.6
21.4
73
214
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.5
21.4
77
234
SPAT1172
SPAT
Guidance concerning hydration
4.2
21.2
58
145
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.9
20.5
32
48
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.7
20.1
32
49
Z75.5
ICD-10 Finland
Holiday relief care
6.1
20.1
35
59
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
19.9
19
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
19.9
19
*
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
+∞
19.9
19
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
19.6
122
506
W19
ICD-10 Finland
Unspecified fall
2.5
19.4
134
585
F05.9
ICD-10 Finland
Delirium, unspecified
4.3
18.9
50
122
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
28.5
18.8
25
9
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
102.2
18.6
20
*
G04BD11
ATC
fesoterodine; oral
4.1
18.6
53
137
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
18.3
218
1194
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
18.2
93
348
N28
ICPC
Limited function/disability (N)
4.9
18.2
40
84
S06.0
ICD-10 Finland
Concussion
2.5
18.1
127
557
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.4
18.1
146
683
R35
ICD-10 Finland
Polyuria
2.7
18.0
105
421
N30.0
ICD-10 Finland
Acute cystitis
2.2
17.9
169
845
F0234, G20,
ICD-10 Finland
+∞
17.8
17
*
SPAT1167
SPAT
Insertion of urinary catheter
3.2
16.9
70
232
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
7.4
16.6
24
33
N05AH02
ATC
clozapine; systemic
28.1
16.6
22
8
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.8
16.3
51
141
S70.0
ICD-10 Finland
Contusion of hip
3.1
16.0
68
229
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.7
15.5
88
348
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
4.0
15.5
45
118
E86
ICD-10 Finland
Volume depletion
3.6
15.5
52
151
WYA20
NOMESCO Finland
Home visit
3.9
15.4
46
123
R44.1
ICD-10 Finland
Visual hallucinations
13.4
15.2
26
20
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
14.9
125
2341
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
16.8
14.8
23
14
G04BD09
ATC
trospium; oral
3.9
14.7
44
118
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
36.7
14.5
18
5
N06AB04
ATC
citalopram; systemic
2.0
14.3
195
1112
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.3
14.0
53
166
K59.0
ICD-10 Finland
Constipation
2.6
14.0
85
347
R55
ICD-10 Finland
Syncope and collapse
2.1
13.6
153
813
F023, G20,
ICD-10 Finland
+∞
13.6
13
*
N05AH03
ATC
olanzapine; systemic
3.4
13.4
48
145
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
13.4
72
276
A04
ICPC
Weakness/tiredness general
2.0
13.0
171
960
R23
ICPC
Voice symptom/complaint
5.0
12.7
27
55
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
32.5
12.6
16
5
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.2
12.1
107
517
N05AX08
ATC
risperidone; systemic
2.2
12.0
113
560
N06DA02
ATC
donepezil; oral
2.1
11.9
120
611
G25.0
ICD-10 Finland
Essential tremor
3.5
11.8
40
117
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
11.6
118
602
SPAT1053
SPAT
Memory test
1.8
11.3
226
1441
R32
ICD-10 Finland
Unspecified urinary incontinence
3.4
11.3
40
120
I95.9
ICD-10 Finland
Hypotension, unspecified
3.8
11.2
34
92
SPAT1254
SPAT
Administration of medicine
1.8
11.2
183
1099
Y94.0
ICD-10 Finland
Accident at home
4.0
11.1
31
79
R47.1
ICD-10 Finland
Dysarthria and anarthria
4.9
11.0
24
50
N30.9
ICD-10 Finland
Cystitis, unspecified
2.4
10.7
73
315
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
10.7
67
278
XKD00
NOMESCO Finland
Uroflowmetry
1.7
10.6
227
1475
N06AX16
ATC
venlafaxine; oral
2.3
10.5
86
402
N04BC01
ATC
bromocriptine; oral
111.3
10.4
11
*
N04BX01
ATC
tolcapone; oral
+∞
10.4
10
*
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.7
10.3
32
88
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.0
10.3
22
45
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.3
10.1
37
114
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.1
10.0
27
67
SPAT1125
SPAT
Stoma care and guidance
3.6
10.0
33
95
130
Kela drug reimbursment
Malignant tumour
0.2
9.9
16
684
N86
ICPC
Multiple sclerosis
26.3
9.8
13
5
S01
ICD-10 Finland
Open wound of head
4.6
9.8
23
51
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
9.6
87
424
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
9.6
168
1027
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
9.4
74
340
M48.0
ICD-10 Finland
Spinal stenosis
1.8
9.4
152
907
N04AA01
ATC
trihexyphenidyl; oral
+∞
9.4
9
*
R5110, ,
SPAT
2.2
9.1
78
372
SPAT1360
SPAT
Extensive global examination
2.2
9.0
79
380
R1260
NOMESCO Finland
Evaluation of communicative skills
3.3
9.0
33
102
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.8
8.9
27
73
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
8.9
76
362
Z50.5
ICD-10 Finland
Speech therapy
6.9
8.9
21
31
F05.1
ICD-10 Finland
Delirium superimposed on dementia
5.0
8.9
19
39
N02AA05
ATC
oxycodone; systemic
1.6
8.9
226
1528
R13
ICD-10 Finland
Dysphagia
2.2
8.7
79
385
ICB01, ,
SPAT
14.2
8.7
14
10
F22.0
ICD-10 Finland
Delusional disorder
4.8
8.6
19
40
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
8.6
45
171
UKC02
NOMESCO Finland
Cystoscopy
1.6
8.5
210
1406
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.9
8.5
39
138
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
8.3
181
1173
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.4
8.3
54
229
F06.0
ICD-10 Finland
Organic hallucinosis
14.6
8.2
13
9
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
8.2
74
361
A03FA01
ATC
metoclopramide; systemic, rectal
0.5
8.1
66
1291
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
8.0
123
720
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
8.0
97
526
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
4.3
8.0
20
47
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.5
8.0
49
202
N06AX21
ATC
duloxetine; oral
2.1
7.8
80
409
S63.1
ICD-10 Finland
Dislocation of finger
4.2
7.8
20
48
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
4.6
7.7
18
40
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
7.6
83
434
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
7.6
108
619
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
7.5
96
530
P20
ICPC
Memory disturbance
1.6
7.5
200
1360
H02AB06
ATC
prednisolone; systemic
0.7
7.5
250
3339
R2110
NOMESCO Finland
Giving the first information
2.5
7.5
48
202
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.8
7.5
130
791
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.4
7.4
26
78
J01EA01
ATC
trimethoprim; systemic
1.6
7.3
239
1704
F0231, G20,
ICD-10 Finland
+∞
7.3
7
*
AA052, ,
NOMESCO Finland
+∞
7.3
7
*
SPAT1301
SPAT
No procedures
1.5
7.3
293
2186
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
7.2
134
830
RF120, ,
NOMESCO Finland
4.5
7.2
17
38
J01CA08
ATC
pivmecillinam; oral
1.5
7.2
277
2045
S01.8
ICD-10 Finland
Open wound of other parts of head
3.7
7.1
22
61
G04CB01
ATC
finasteride; oral
1.6
7.0
178
1196
M04AA01
ATC
allopurinol; systemic
0.5
7.0
67
1240
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
6.9
38
148
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.9
744
6738
F05.8
ICD-10 Finland
Other delirium
5.7
6.8
18
32
G21.8
ICD-10 Finland
Other secondary parkinsonism
40.4
6.8
8
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
40.4
6.8
8
*
K11.72
ICD-10 Finland
Xerostomia
40.4
6.8
8
*
ZXD35
NOMESCO Finland
Usual procedure
2.6
6.7
39
157
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.1
6.5
*
218
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.5
6.4
47
956
N06AX26
ATC
vortioxetine; oral
2.5
6.3
37
149
WX212
NOMESCO Finland
Femoral plexus blockade
2.7
6.3
32
120
F02.33
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly depression
+∞
6.3
6
*
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
26.9
6.2
8
*
NF3AA
NOMESCO Finland
Femur X-ray examination
2.8
6.2
31
115
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.2
164
1110
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.1
6.2
*
210
H50.52
ICD-10 Finland
Exophoria
5.8
6.2
16
28
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.1
6.1
24
78
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
6.1
468
5436
F0029, G308,
ICD-10 Finland
10.1
6.0
11
11
N05BA01
ATC
diazepam; systemic, rectal
1.7
6.0
114
709
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.0
374
3006
G04BD08
ATC
solifenacin; oral
1.9
6.0
76
419
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
318
1939
2.00
20.18
2.1
1.8
1103.35
1182.07
nmol/l
0.78
213
1425
349
2369
1.78
14.79
2.8
2.2
317.50
259.52
u/l
0.43
325
2200
21
14
15.33
13.14
2.0
1.3
70.71
84.89
nmol/l
—
14
9
137
2347
0.51
12.03
2.8
3.3
588.00
340.13
mg/l
0.18
79
1555
451
3427
1.64
11.74
2.4
2.2
83.78
92.08
pmol/l
4.12
276
1780
138
2331
0.52
11.48
2.9
3.2
7.13
7.09
mmol/l
0.04
101
1877
154
2494
0.54
11.07
3.6
3.8
5.68
9.93
mg/mmol
2.58
90
1621
495
5951
0.62
10.77
3.8
4.8
1.41
1.41
mmol/l
0.08
416
5227
504
6030
0.62
10.68
3.7
4.8
4.20
4.28
mmol/l
0.91
424
5354
231
1514
1.71
10.40
2.1
1.8
—
—
—
0
0
303
2133
1.64
10.37
1.7
1.7
17.15
19.64
nmol/l
2.44
267
1792
590
4876
1.63
10.30
7.4
5.3
5434.62
2668.25
e6/l
0.25
16
100
103
524
2.09
10.19
1.4
1.5
—
—
—
0
0
481
5769
0.64
9.70
3.3
4.3
1.10
1.24
mmol/l
6.28
395
4999
532
6227
0.64
9.40
4.2
5.5
2.39
2.44
mmol/l
0.60
441
5492
306
2291
1.51
7.50
3.7
3.5
0.45
0.54
e6/l
0.45
245
1819
162
1055
1.66
7.23
2.0
1.7
—
—
—
0
0
97
1612
0.55
7.08
1.4
1.6
1.05
1.26
mmol/l
3.53
81
1309
373
2946
1.46
6.84
3.9
3.5
—
—
—
0
0
327
2519
1.47
6.82
3.9
3.6
51.14
109.63
e6/l
1.24
261
2013
158
1050
1.61
6.46
2.0
1.8
—
—
—
0
0
253
1876
1.49
6.30
1.8
1.8
393.08
7842248.90
pmol/l
0.80
200
1492
45
925
0.46
6.29
3.7
3.9
3.13
27.39
ug/l
2.00
37
796
478
3998
1.42
6.22
5.2
6.9
1.21
1.21
mmol/l
0.54
376
3343
44
204
2.22
5.56
1.5
1.3
—
—
—
0
0
44
204
2.22
5.56
1.5
1.3
—
—
—
0
0
348
2802
1.40
5.38
4.5
4.1
123.59
134.31
e6/l
0.11
269
2120
19
58
3.33
5.33
1.1
1.0
33.07
41.78
ng/l
0.52
14
32
338
2714
1.40
5.29
2.6
2.1
—
—
—
0
0
324
2587
1.40
5.23
6.3
4.9
—
—
—
0
0
537
6037
0.72
5.20
6.1
6.9
40.58
41.57
mmol/mol
1.66
456
5411
18
54
3.38
5.18
2.8
2.5
—
—
—
0
0
403
3343
1.38
5.14
7.8
6.0
0.00
0.00
estimate
-0.00
93
652
407
3384
1.37
5.11
5.7
4.4
0.00
0.00
estimate
0.50
103
721
34
147
2.37
5.06
1.2
1.2
589.24
520.24
mg/l
0.30
29
136
185
1342
1.48
5.02
3.2
3.3
2.60
1.99
e6/l
0.46
108
802
408
3401
1.37
5.01
5.8
4.4
0.00
0.00
estimate
-0.00
97
645
526
5912
0.73
4.90
22.4
18.6
77.48
68.65
ml/min/173m2
20.11
442
4935
141
1957
0.67
4.61
2.1
3.0
7854.53
8528.84
umol/l
0.04
107
1637
563
6227
0.74
4.41
4.6
5.3
6.02
6.18
mmol/l
2.71
454
5446
21
497
0.41
4.23
1.2
1.2
—
—
—
0
0
284
2283
1.36
4.22
2.1
2.2
2.72
3.17
mg/l
3.64
210
1910
187
1410
1.41
4.08
3.0
3.0
1.02
1.14
e6/l
0.17
112
863
407
3469
1.32
4.01
3.4
4.8
33.74
34.05
g/l
0.49
355
3201
58
340
1.76
3.83
2.1
1.8
—
—
—
0
0
504
4449
1.31
3.75
5.0
5.1
6.44
6.94
mmol/l
10.53
474
4204
52
856
0.58
3.57
1.2
1.2
68.93
42.19
iu/ml
0.27
17
275
28
131
2.17
3.54
1.3
1.2
1.90
67.93
e6/l
0.89
20
108
28
131
2.17
3.54
1.5
1.3
257.64
1123.59
e6/l
0.52
22
109
420
3643
1.29
3.47
4.7
6.0
1.20
1.21
mmol/l
0.80
366
3276
54
323
1.72
3.35
2.2
2.2
436.48
604.96
ug/l
0.34
48
303
226
1813
1.33
3.29
3.2
2.7
4.57
4.29
e6/l
0.22
199
1640
125
914
1.43
3.22
6.0
3.8
—
—
—
0
0
377
3253
1.28
3.15
5.6
4.4
41.96
58.02
ng/l
0.82
314
2608
235
1914
1.31
3.05
6.0
4.6
0.00
0.00
estimate
-0.00
84
609
26
126
2.10
3.05
1.1
1.2
3.69
3.93
mmol/l
0.62
21
116
51
806
0.61
2.99
1.3
1.2
14.34
14.87
u/ml
0.02
21
262
153
1957
0.74
2.98
2.8
3.4
0.76
0.81
ug/l
0.25
102
1434
86
596
1.49
2.93
2.2
1.6
—
—
—
0
0
58
373
1.59
2.77
2.2
1.9
—
—
—
0
0
8
214
0.37
2.69
1.0
1.4
—
—
—
0
0
15
61
2.48
2.63
1.5
1.3
—
—
—
0
0
7
195
0.35
2.56
1.0
2.6
1.39
1.91
mg/l
—
7
170
15
62
2.44
2.55
1.5
1.3
—
—
—
0
0
31
172
1.83
2.53
1.6
2.6
25.54
34.48
umol/l
2.39
24
151
0
67
0.00
2.39
0.0
1.7
—
—
—
0
0
318
2768
1.23
2.29
2.1
2.2
72.38
79.26
nmol/l
4.45
252
2364
29
490
0.58
2.26
1.5
2.2
12.20
11.44
nmol/l
0.17
22
413
0
61
0.00
2.24
0.0
2.4
—
72.17
—
0
12
11
41
2.70
2.21
1.1
1.0
—
—
—
0
0
82
602
1.40
2.11
1.6
2.0
394.72
383.04
nmol/l
0.21
61
537
5
10
5.02
2.07
1.6
1.4
62.40
117.80
nmol/24h
—
5
10
11
44
2.52
2.01
1.5
1.3
—
—
—
0
0
11
44
2.52
2.01
1.5
1.3
—
—
—
0
0
156
1271
1.28
1.99
1.7
3.1
0.83
0.81
mmol/l
1.08
137
1183
18
91
2.00
1.96
1.5
1.5
—
—
—
0
0
93
707
1.35
1.95
2.9
3.8
1.22
1.22
mmol/l
0.05
77
604
35
541
0.63
1.93
2.5
3.1
67.47
55.18
ml/min/173m2
0.86
17
235
7
171
0.40
1.92
1.4
1.5
—
—
—
0
0
18
92
1.98
1.91
1.5
1.5
—
—
—
0
0
18
92
1.98
1.91
1.5
1.5
—
—
—
0
0
18
92
1.98
1.91
1.5
1.5
—
—
—
0
0
5
142
0.35
1.89
1.0
1.2
—
33.26
—
0
5
18
93
1.95
1.86
1.5
1.5
—
—
—
0
0
181
1518
1.24
1.81
5.3
5.0
1.02
1.02
kg/l
1.53
25
246
8
29
2.77
1.79
1.0
1.2
—
—
—
0
0
5
135
0.37
1.76
1.0
1.2
—
2.36
—
0
16
7
164
0.42
1.67
1.1
1.3
—
—
—
0
0
60
437
1.40
1.66
4.7
3.9
45.82
47.39
%
0.18
60
432
17
90
1.91
1.66
1.5
1.5
—
—
—
0
0
6
146
0.41
1.65
1.8
1.8
—
—
—
0
0
48
336
1.45
1.65
5.1
4.6
25.69
24.89
mmol/l
1.14
40
308
502
4666
1.17
1.60
3.6
3.7
15.43
15.19
pmol/l
1.10
418
4058
11
50
2.22
1.57
1.1
1.1
—
—
—
0
0
635
6654
0.84
1.55
9.1
11.5
16.95
23.83
u/l
13.40
556
6331
117
952
1.26
1.53
10.1
9.5
—
—
—
0
0
0
42
0.00
1.53
0.0
1.0
—
—
—
0
0
0
42
0.00
1.53
0.0
1.1
—
—
—
0
0
43
300
1.46
1.52
1.3
1.3
—
—
—
0
0
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
246
2776
0.84
1.50
4.1
4.9
20.58
21.67
%
0.60
127
1504
21
341
0.61
1.47
2.6
2.9
—
—
—
0
0
106
861
1.26
1.42
2.7
3.6
2.65
1.99
mmol/l
1.32
91
693
5
17
2.95
1.36
1.8
1.9
2.88
14.52
nmol/l
—
5
12
71
899
0.77
1.30
3.5
4.8
36.85
33.11
%
1.08
33
571
11
55
2.01
1.27
1.1
1.1
—
—
—
0
0
62
478
1.32
1.25
3.1
3.0
0.37
0.35
e6/l
0.04
62
470
75
594
1.29
1.25
6.1
5.7
25.29
24.32
mmol/l
2.03
70
560
54
414
1.32
1.15
1.9
1.8
1.58
3.07
ug/l
0.55
36
352
668
6427
1.16
1.12
24.7
19.2
31.64
28.80
mg/l
1.24
610
5366
103
861
1.22
1.10
2.5
2.6
5.87
6.39
ug/l
0.15
49
740
9
49
1.85
0.98
1.0
1.2
—
—
—
0
0
303
2789
1.13
0.98
2.5
2.9
157.30
162.47
ug/l
0.16
244
2474
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
64
787
0.80
0.97
3.1
6.8
10.60
12.02
mmol/l
0.95
55
741
6
119
0.50
0.94
1.0
1.3
—
—
—
0
0
292
2689
1.13
0.93
2.2
3.4
2.33
2.34
mmol/l
1.41
237
2312
66
538
1.24
0.91
4.2
4.1
2.12
1.91
mmol/l
0.18
45
402
16
102
1.58
0.91
3.3
2.7
—
—
—
0
0
7
128
0.54
0.88
1.1
1.6
—
—
—
0
0
7
128
0.54
0.88
1.1
1.6
—
—
—
0
0
13
80
1.63
0.85
2.2
1.5
—
—
—
0
0
10
166
0.60
0.84
1.4
2.1
8.33
13.10
mg/l
—
10
150
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
32
1.88
0.82
1.2
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
2.5
—
787.67
—
0
6
14
211
0.66
0.79
1.9
3.0
7.99
7.66
kpa
0.45
14
206
87
743
1.19
0.79
1.8
2.1
0.20
0.20
g/l
0.03
77
677
5
100
0.50
0.77
1.4
1.2
—
—
—
0
0
7
39
1.80
0.72
1.7
2.1
—
—
—
0
0
130
1156
1.15
0.72
1.7
2.4
1.59
1.79
%
1.60
99
1018
11
169
0.65
0.69
2.5
2.1
92.36
84.86
%
0.59
11
161
13
192
0.67
0.68
2.2
2.2
3.28
3.72
g/l
0.64
13
178
368
3876
0.91
0.66
6.3
8.3
4.68
4.41
e9/l
1.02
312
3362
182
1668
1.11
0.64
2.6
3.2
2.46
2.47
mmol/l
0.38
149
1454
22
164
1.35
0.63
1.5
1.4
—
—
—
0
0
13
187
0.69
0.61
1.3
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
14
197
0.71
0.59
1.0
1.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
430
4120
1.08
0.58
15.9
21.7
1.32
1.42
inr
1.47
113
1151
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
66
569
1.17
0.57
4.3
4.1
5.18
5.15
kpa
0.08
58
540
6
36
1.67
0.56
1.2
1.2
—
—
—
0
0
5
87
0.57
0.56
1.0
1.2
—
—
—
0
0
75
655
1.16
0.56
1.9
1.7
—
—
—
0
0
13
183
0.71
0.56
1.2
1.5
—
—
—
0
0
92
1032
0.88
0.54
1.8
3.8
227.83
256.09
u/l
1.55
78
966
10
66
1.52
0.52
1.7
1.4
—
54.44
—
0
9
595
5792
1.08
0.52
4.8
4.7
1.95
2.09
mu/l
1.80
504
5083
176
1633
1.10
0.50
4.2
4.2
149.83
292.19
ng/l
0.83
158
1460
329
3447
0.93
0.50
4.3
5.8
2.72
5.09
ug/l
1.11
266
3013
19
246
0.77
0.49
2.2
3.4
24.51
24.85
mmol/l
0.17
19
239
28
345
0.81
0.49
2.4
2.6
—
12.89
—
0
17
118
1074
1.11
0.49
4.5
6.6
5.08
5.05
kpa
0.15
110
1014
118
1075
1.11
0.48
4.5
6.6
11.17
11.55
kpa
0.35
109
1015
19
244
0.77
0.47
1.1
1.1
81.17
126.39
iu/ml
—
6
80
118
1079
1.11
0.45
4.5
6.6
1.80
1.21
mmol/l
1.26
95
823
33
275
1.21
0.44
2.5
2.7
4.42
4.24
pmol/l
0.58
25
238
7
51
1.38
0.44
1.1
1.5
—
—
—
0
0
9
131
0.68
0.43
1.1
1.5
—
—
—
0
0
5
31
1.62
0.43
1.6
2.8
—
—
—
0
0
5
31
1.62
0.43
1.6
2.8
—
—
—
0
0
6
95
0.63
0.42
1.7
3.8
—
—
—
0
0
140
1298
1.09
0.42
2.0
1.9
29.80
30.27
s
0.49
134
1249
15
195
0.77
0.42
1.3
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
282
2952
0.93
0.41
3.2
3.4
1534.22
2111.26
ng/l
1.49
235
2583
154
1436
1.09
0.41
1.7
1.6
1.81
1.52
mg/l
0.34
121
1141
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
27.33
—
0
10
189
2004
0.93
0.39
2.0
3.0
40.55
36.04
u/l
0.20
168
1905
16
204
0.78
0.39
1.7
2.4
36.09
87.96
ug/min
—
7
121
30
356
0.84
0.39
1.2
1.3
—
—
—
0
0
5
37
1.35
0.37
1.2
1.8
—
—
—
0
0
5
37
1.35
0.37
1.2
1.8
—
—
—
0
0
20
245
0.81
0.36
1.5
1.6
—
—
—
0
0
12
90
1.34
0.36
1.3
1.5
—
—
—
0
0
551
5388
1.06
0.35
5.2
7.6
83.19
81.77
u/l
0.21
490
5012
21
251
0.83
0.31
1.9
1.6
—
—
—
0
0
10
131
0.76
0.31
1.3
1.1
—
19.14
—
0
7
23
194
1.19
0.29
2.3
2.5
16.80
15.49
%
—
10
93
191
1821
1.06
0.29
3.4
4.2
78.55
80.97
%
0.68
184
1776
18
217
0.83
0.29
1.2
1.4
—
—
—
0
0
144
1362
1.07
0.28
1.8
2.5
11.17
11.97
umol/l
0.85
119
1254
9
119
0.75
0.27
1.1
1.5
—
—
—
0
0
9
120
0.75
0.27
1.0
1.1
—
—
—
0
0
236
2272
1.05
0.26
2.6
2.5
54.18
94.74
u/l
0.59
217
2081
133
1259
1.07
0.26
1.8
2.5
2.11
2.24
g/l
1.74
103
1147
42
467
0.89
0.26
1.6
1.9
1.36
1.53
g/l
0.74
31
409
677
6851
0.95
0.25
33.1
28.3
126.87
131.12
g/l
12.34
649
6685
677
6850
0.95
0.24
32.9
28.1
4.19
4.34
e12/l
10.64
643
6588
677
6850
0.95
0.24
32.7
28.3
37.58
38.78
%
4.16
583
6229
677
6849
0.95
0.24
32.9
28.1
231.54
233.05
e9/l
0.25
642
6619
5
38
1.32
0.23
1.4
1.8
—
—
—
0
0
24
209
1.15
0.23
1.4
1.4
291.67
269.07
ug/g
0.18
15
124
7
93
0.75
0.22
1.0
1.5
—
69.03
—
0
62
12
146
0.82
0.22
1.4
1.7
—
—
—
0
0
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
126
1200
1.06
0.21
1.8
2.6
21.02
21.84
%
0.28
87
1017
5
42
1.19
0.21
1.2
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
11.8
—
6.63
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
8
105
0.76
0.21
1.0
1.0
—
—
—
0
0
22
192
1.15
0.21
7.8
4.0
21.89
30.64
mg/l
0.82
16
126
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
14
117
1.20
0.20
1.0
1.1
—
—
—
0
0
519
5270
0.96
0.20
26.2
22.7
14.59
15.69
%
5.75
501
5159
0
14
0.00
0.20
0.0
1.0
—
1701.86
—
0
14
13
109
1.20
0.18
1.3
1.4
—
—
—
0
0
324
3169
1.04
0.18
5.4
5.8
22.19
24.88
%
4.45
288
2934
173
1789
0.96
0.17
2.2
2.5
—
—
—
0
0
69
651
1.06
0.17
2.1
2.3
40.81
34.69
u/l
0.25
54
548
8
69
1.16
0.16
1.4
1.6
—
—
—
0
0
60
637
0.94
0.16
2.5
3.9
77.16
100.49
ng/l
1.54
45
541
6
76
0.79
0.15
1.2
1.6
—
—
—
0
0
6
76
0.79
0.15
1.2
1.6
—
—
—
0
0
6
76
0.79
0.15
1.2
1.6
—
—
—
0
0
95
909
1.05
0.15
2.7
3.0
232.28
256.23
ng/l
0.20
86
836
316
3099
1.03
0.15
5.3
5.5
62.71
59.43
%
4.89
280
2878
21
188
1.12
0.15
1.3
1.5
14387.15
16403.66
e6/l
0.09
13
132
9
109
0.82
0.13
1.1
1.5
—
—
—
0
0
29
314
0.92
0.13
1.2
3.3
—
1.99
—
0
25
30
323
0.93
0.12
1.3
3.3
25.17
92.57
mg/l
1.08
21
263
675
6795
0.97
0.12
28.0
23.5
3.96
4.03
mmol/l
7.89
649
6581
31
288
1.08
0.12
1.3
2.4
36.44
36.69
g/l
0.07
18
245
30
322
0.93
0.11
1.3
3.3
47.49
79.95
mg/l
0.85
22
259
35
372
0.94
0.10
1.3
2.5
—
—
—
0
0
35
372
0.94
0.10
1.3
2.5
6.81
7.52
g/l
1.22
22
329
35
371
0.94
0.09
1.3
2.5
3.97
3.59
g/l
0.37
23
329
108
1111
0.97
0.09
2.6
5.4
0.95
1.03
mmol/l
3.70
98
1020
5
46
1.09
0.09
1.2
1.7
—
—
—
0
0
5
46
1.09
0.09
1.2
1.7
—
—
—
0
0
675
6786
0.98
0.09
28.0
23.3
139.84
139.49
mmol/l
2.58
650
6579
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
7
66
1.06
0.08
2.0
1.6
284.29
330.18
mu/l
—
7
60
7
67
1.05
0.08
1.6
1.1
—
—
—
0
0
6
73
0.82
0.07
1.0
1.2
—
53.34
—
0
12
12
108
1.11
0.07
2.2
1.3
—
—
—
0
0
7
81
0.86
0.07
1.3
1.3
11.29
14.00
u/l
—
7
74
7
83
0.84
0.07
1.1
1.8
—
—
—
0
0
33
346
0.95
0.06
1.3
2.5
8.76
10.72
g/l
2.98
20
301
8
94
0.85
0.06
1.3
1.2
9.13
13.06
u/l
—
8
86
20
187
1.07
0.06
1.1
1.2
—
—
—
0
0
9
105
0.86
0.06
1.1
1.5
—
—
—
0
0
330
3272
1.01
0.05
2.4
2.8
—
—
—
0
0
20
188
1.07
0.05
1.1
1.2
—
—
—
0
0
33
344
0.96
0.05
1.3
2.6
3.08
3.05
g/l
0.04
20
301
16
149
1.08
0.05
1.3
1.6
—
—
—
0
0
389
3864
1.01
0.05
3.8
6.1
12.57
12.71
umol/l
0.08
353
3645
10
110
0.91
0.05
1.3
1.6
—
—
—
0
0
24
252
0.95
0.05
1.3
2.6
0.00
0.00
g/l
-0.00
17
228
80
784
1.02
0.04
1.4
2.7
65.25
65.68
g/l
0.18
59
700
41
423
0.97
0.04
1.6
1.6
1.51
1.75
%
2.11
34
327
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
351
0.97
0.03
1.6
2.4
0.51
0.34
u/ml
0.73
17
198
113
1116
1.01
0.03
1.2
1.2
0.63
1.36
u/ml
2.12
24
264
501
4994
1.01
0.02
3.6
4.2
12.93
15.84
mm/h
4.40
437
4504
360
3592
1.00
0.01
3.2
3.2
57.16
58.91
u/l
0.07
321
3224
25
256
0.98
0.00
1.3
2.6
0.00
0.00
g/l
-0.00
17
229
21
212
0.99
0.00
1.1
1.3
—
—
—
0
0
31
312
0.99
0.00
1.5
2.7
1.22
1.39
g/l
0.07
21
262
81
809
1.00
0.00
1.8
2.8
11.06
10.52
umol/l
0.07
65
700
27
271
1.00
0.00
1.3
2.5
0.00
0.02
g/l
0.96
19
243
13
127
1.02
0.00
1.9
2.7
5.02
4.64
e9/l
0.17
13
127
13
131
0.99
0.00
2.0
3.1
57.15
61.37
%
0.52
13
131
12
115
1.04
0.00
1.8
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
35.80
—
0
5
8
88
0.91
-0.00
1.4
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
6.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.1
—
13.67
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
1.3
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
79
0.89
-0.00
1.1
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
78.00
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PD_DEMENTIA – Dementia due to Parkinson's disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).